Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.7528706648314648e-06,8.102735211731751,107.39572464181731,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH1', 'GPR34', 'HRH2', 'GPR65', 'ADRB2', 'OPRM1']",0.0006579973901304072,0,0,11
2,TYROBP causal network in microglia WP3945,3.209743366489791e-06,5.430782608695652,68.69570474427874,"['STAT5A', 'IGSF6', 'LOXL3', 'TCIRG1', 'TNFRSF1B', 'ADAP2', 'BIN2', 'NPC2', 'DPYD', 'ITGAX', 'SPP1', 'HCLS1', 'GAL3ST4', 'C1QC']",0.0006579973901304072,0,0,14
3,Complement and Coagulation Cascades WP558,5.02554774718498e-06,12.3263339070568,150.39330546896622,"['C1QB', 'C1QA', 'SERPINA1', 'PROS1', 'C5AR1', 'PLAT', 'CD55', 'C1QC']",0.0006669479845804136,0,0,8
4,Complement system WP2806,6.506809605662571e-06,6.803252595155709,81.24894146735987,"['FCGR3A', 'SELPLG', 'CD93', 'PROS1', 'C5AR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CD55', 'TLR2']",0.0006669479845804136,0,0,11
5,Lung fibrosis WP3624,4.2734708627458336e-05,8.212966150315548,82.6265387236822,"['SERPINA1', 'FAM13A', 'PDGFB', 'SPP1', 'HMOX1', 'ATP11A', 'IGF1', 'FGF2']",0.0035042461074515836,0,0,8
6,Vitamin D Receptor Pathway WP2877,6.884713588047431e-05,4.191333912037037,40.16815960820578,"['CEBPA', 'TNFAIP3', 'PRDM1', 'ADRB2', 'HIF1A', 'DUSP10', 'BCL6', 'SPP1', 'PRKCQ', 'CD14', 'S100A9', 'S100A8', 'PPARD']",0.004704554285165744,0,0,13
7,Monoamine GPCRs WP58,0.00019434339606836003,30.632478632478634,261.78160537500725,"['CHRM3', 'HRH1', 'HRH2', 'ADRB2']",0.011382970341146801,0,0,4
8,Nuclear Receptors Meta-Pathway WP2882,0.0002794490852298779,2.5720167461461685,21.04601685492235,"['SRGN', 'CPT1A', 'SERPINA1', 'SRC', 'ABCB4', 'STAT3', 'PDGFB', 'TNFAIP3', 'NRG1', 'SLC5A3', 'SLC7A5', 'SEC14L1', 'PDE4B', 'HMOX1', 'STOM', 'PLTP', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.014321765618031244,0,0,21
9,Complement Activation WP545,0.0004313333815557642,20.41937321937322,158.22215279386091,"['C1QB', 'C1QA', 'CD55', 'C1QC']",0.01964963182642926,0,0,4
10,Toll-like Receptor Signaling Pathway WP75,0.0005348862402089735,3.495896144664988,26.3361814252855,"['IFNAR2', 'IRF7', 'SPP1', 'LY96', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR3', 'RELA', 'MAP2K6', 'TLR2']",0.021930335848567916,0,0,12
11,Cardiac Progenitor Differentiation WP2406,0.0007449494438455363,9.582619863013699,69.0158892221334,"['NOTCH1', 'NRG1', 'ROR2', 'IGF1', 'FGF2']",0.025452439331389156,0,0,5
12,Differentiation Pathway WP2848,0.0007449494438455363,9.582619863013699,69.0158892221334,"['NOTCH1', 'WNT5A', 'PDGFB', 'IGF1', 'FGF2']",0.025452439331389156,0,0,5
13,Regulation of toll-like receptor signaling pathway WP1449,0.001022244470856135,2.8850550724637682,19.8657812582017,"['IFNAR2', 'LY96', 'TNFAIP3', 'SMAD6', 'RELA', 'IRF7', 'SPP1', 'MAP3K8', 'CD14', 'TLR5', 'IKBKE', 'TLR3', 'MAP2K6', 'TLR2']",0.03224001792700118,0,0,14
14,IL-4 signaling pathway WP395,0.0012281996734884624,3.957783251231527,26.525878106591318,"['STAT5A', 'CEBPA', 'HRH1', 'IL4R', 'NFIL3', 'FES', 'STAT3', 'JAK3', 'RELA']",0.033570791075351304,0,0,9
15,Regulatory circuits of the STAT3 signaling pathway WP4538,0.0012281996734884624,3.957783251231527,26.525878106591318,"['PTPRT', 'IFNAR2', 'IL15RA', 'SRC', 'IL3RA', 'STAT3', 'IL21R', 'JAK3', 'CSF2RA']",0.033570791075351304,0,0,9
16,PTF1A related regulatory pathway WP4147,0.002124451881658298,22.935153583617748,141.14847279872617,"['NOTCH1', 'PROX1', 'RBPJ']",0.054439079467493885,0,0,3
17,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.0027719278843450776,5.113779302458548,30.111017747114527,"['IFNAR2', 'OAS1', 'IRF7', 'IKBKE', 'TLR3', 'TLR2']",0.06685237838714599,0,0,6
18,Toll-like Receptor Signaling related to MyD88 WP3858,0.003460349153248263,4.844091360476663,27.448490419756563,"['IRF7', 'TLR5', 'IKBKE', 'RELA', 'TLR3', 'TLR2']",0.07881906404621045,0,0,6
19,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.0037969420700023396,inf,inf,"['FMO4', 'FMO5']",0.08193401308952417,0,0,2
20,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.00405457068419988,15.288395904436861,84.20711587481455,"['LIPC', 'LIPG', 'APOE']",0.08311869902609755,0,0,3
21,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.004757682397393092,7.652991452991453,40.928157122194335,"['RAB27A', 'RAB27B', 'MYRIP', 'EXPH5']",0.08810741335062719,0,0,4
22,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.004757682397393092,7.652991452991453,40.928157122194335,"['STAT3', 'SPP1', 'HSPB1', 'IGF1']",0.08810741335062719,0,0,4
23,Neovascularisation processes WP4331,0.004942610992840062,5.472113502935421,29.056165066500444,"['NOTCH1', 'CXCL12', 'PDGFB', 'HIF1A', 'RELA']",0.08810741335062719,0,0,5
24,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.006541125322568835,6.801899335232669,34.21114619634934,"['CYSLTR1', 'LTC4S', 'ALOX15B', 'PPARD']",0.10678939212681332,0,0,4
25,Glucocorticoid Receptor Pathway WP2880,0.006661729658335108,3.5809851088201605,17.945663259305125,"['SRGN', 'MGAM', 'SEC14L1', 'PDE4B', 'TNFAIP3', 'STOM', 'CPEB4']",0.10678939212681332,0,0,7
26,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.006772010232432064,11.465017064846416,57.267270725343266,"['APOE', 'RELA', 'TLR2']",0.10678939212681332,0,0,3
27,Osteoclast Signaling WP12,0.010342840986589932,9.17098976109215,41.92481918780116,"['PDGFB', 'SPP1', 'TNFRSF11A']",0.15705795572229156,0,0,3
28,Angiogenesis WP1539,0.01131731337361921,5.563947163947164,24.934392828517602,"['SRC', 'PDGFB', 'HIF1A', 'FGF2']",0.1657178029708527,0,0,4
29,Endochondral Ossification with Skeletal Dysplasias WP4808,0.01227643510209747,3.537142103179839,15.563685939740036,"['SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2']",0.16777794639533208,0,0,6
30,Endochondral Ossification WP474,0.01227643510209747,3.537142103179839,15.563685939740036,"['SPP1', 'ENPP1', 'PLAT', 'IGF1', 'FGF2', 'SLC38A2']",0.16777794639533208,0,0,6
31,MECP2 and Associated Rett Syndrome WP3584,0.013536989167255242,2.790799561883899,12.006939010212841,"['RBFOX1', 'CEBPD', 'BCL6', 'YBX1', 'IGF1', 'FGF2', 'FKBP5', 'EZH2']",0.17350722430804383,0,0,8
32,Statin inhibition of cholesterol production WP430,0.014367834555284889,5.0997150997151,21.636883975228304,"['LIPC', 'APOC1', 'APOE', 'PLTP']",0.17350722430804383,0,0,4
33,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.014367834555284889,5.0997150997151,21.636883975228304,"['GSDMD', 'FCGR2A', 'IKBKE', 'RELA']",0.17350722430804383,0,0,4
34,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.014811592318979352,7.6416382252559725,32.18921763985598,"['STAT3', 'JAK3', 'RELA']",0.17350722430804383,0,0,3
35,Peptide GPCRs WP24,0.014811592318979352,7.6416382252559725,32.18921763985598,"['CX3CR1', 'C5AR1', 'OPRM1']",0.17350722430804383,0,0,3
36,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.016637964107796527,3.8279109589041096,15.679384352597477,"['SRC', 'LY96', 'PLAT', 'CD14', 'TLR3']",0.189487924561016,0,0,5
37,Adipogenesis WP236,0.017586325205085282,2.467795566502463,9.97145782195206,"['STAT5A', 'CEBPA', 'WNT5B', 'CEBPD', 'NAMPT', 'STAT3', 'IGF1', 'HIF1A', 'PPARD']",0.19487549551580988,0,0,9
38,MAPK Signaling Pathway WP382,0.018534024859856012,1.8460061065694868,7.3621438165182305,"['DUSP1', 'LRRK2', 'HSPA6', 'PDGFB', 'HSPB1', 'FGF2', 'DUSP6', 'RELA', 'CACNB4', 'DUSP10', 'RASA2', 'MKNK2', 'MAP3K8', 'CD14', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.19997237348792013,0,0,17
39,Hematopoietic Stem Cell Differentiation WP2849,0.019583148675137406,3.645221787345075,14.336970210138864,"['SEC14L2', 'STAT5A', 'NOTCH1', 'PIM1', 'RUNX1']",0.2007272739201584,0,0,5
40,Oxidative Damage WP3941,0.019583148675137406,3.645221787345075,14.336970210138864,"['C1QB', 'C1QA', 'C5AR1', 'TNFRSF1B', 'C1QC']",0.2007272739201584,0,0,5
41,"GPCRs, Other WP117",0.026433019669837424,4.078404558404558,14.81742006082379,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADRB2']",0.2643301966983742,0,0,4
42,Prolactin Signaling Pathway WP2037,0.027433820460677605,2.405858729033782,8.65141675288994,"['STAT5A', 'PTPN1', 'SRC', 'PXN', 'STAT3', 'NEK3', 'CTSD', 'RELA']",0.26780634259232905,0,0,8
43,GDNF/RET signaling axis WP4830,0.0335129201840044,10.174900624645089,34.552174154010764,"['ROBO2', 'SALL1']",0.29362495894050344,0,0,2
44,Inflammatory Response Pathway WP453,0.0335129201840044,10.174900624645089,34.552174154010764,"['IL4R', 'TNFRSF1B']",0.29362495894050344,0,0,2
45,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.0335129201840044,10.174900624645089,34.552174154010764,"['STAT3', 'CHI3L1']",0.29362495894050344,0,0,2
46,Genes controlling nephrogenesis WP4823,0.03378897188508065,5.092718998862344,17.252200836204473,"['ROBO2', 'CXCL12', 'PDGFB']",0.29362495894050344,0,0,3
47,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.03378897188508065,5.092718998862344,17.252200836204473,"['PDGFB', 'IGF1', 'FGF2']",0.29362495894050344,0,0,3
48,Allograft Rejection WP2328,0.03437560494913211,2.702451821208758,9.108365574623265,"['C1QB', 'C1QA', 'CXCL12', 'LRRK2', 'CD55', 'C1QC']",0.29362495894050344,0,0,6
49,Ectoderm Differentiation WP2858,0.035678381675317554,2.046516983304548,6.821471547086394,"['SDCBP', 'PTPRB', 'PLCXD3', 'PIM1', 'PLXNA2', 'HMGB2', 'SORCS1', 'ROR2', 'ASTN1', 'PPARD']",0.2985333976914326,0,0,10
50,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.03825232793207707,2.6249448664543005,8.566641075299094,"['STAT5A', 'ANGPT2', 'SRC', 'PXN', 'STAT3', 'RELA']",0.31142549294654864,0,0,6
51,NRF2 pathway WP2884,0.03873829302505849,2.229885776873729,7.249195175004857,"['SERPINA1', 'PDGFB', 'HMOX1', 'NRG1', 'SLC5A3', 'FTL', 'PPARD', 'HSPA1A']",0.31142549294654864,0,0,8
52,Notch Signaling Pathway Netpath WP61,0.04239681942323605,2.5517438536306463,8.065250696224524,"['NOTCH1', 'SRC', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.331809751683078,0,0,6
53,Acute viral myocarditis WP4298,0.04289248009561741,2.331241595696997,7.341216762916731,"['SGCB', 'SRC', 'STAT3', 'CASP1', 'TLR5', 'TLR3', 'CD55']",0.331809751683078,0,0,7
54,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.04434741283020095,2.833269913749366,8.827621640642736,"['STAT5A', 'SRC', 'FES', 'STAT3', 'RELA']",0.3367118381552294,0,0,5
55,Spinal Cord Injury WP2431,0.046776643736339066,2.2813848066096365,6.986447278669315,"['C1QB', 'SEMA6A', 'FCGR2A', 'TNFSF13', 'PLXNA2', 'LILRB3', 'TNFSF13B']",0.34102191105618346,0,0,7
56,Farnesoid X receptor pathway WP2879,0.048242124003069854,7.630323679727428,23.13149942526665,"['ABCB4', 'FKBP5']",0.34102191105618346,0,0,2
57,FOXP3 in COVID-19 WP5063,0.048242124003069854,7.630323679727428,23.13149942526665,"['STAT5A', 'STAT3']",0.34102191105618346,0,0,2
58,Macrophage markers WP4146,0.048242124003069854,7.630323679727428,23.13149942526665,"['CD163', 'CD14']",0.34102191105618346,0,0,2
59,PPAR signaling pathway WP3942,0.04972302504164689,2.7317759295499022,8.198844055897961,"['CPT1A', 'ACSL1', 'OLR1', 'PLTP', 'PPARD']",0.3455328858826309,0,0,5
60,IL-9 signaling pathway WP22,0.0510304249963919,4.165839280173751,12.394760147691532,"['STAT5A', 'STAT3', 'JAK3']",0.34617253894548244,0,0,3
61,Modulators of TCR signaling and T cell activation WP5072,0.051503719208962025,2.416899882639704,7.168769778177087,"['GNA13', 'RASA2', 'TNFAIP3', 'MAP3K8', 'PRKCQ', 'RELA']",0.34617253894548244,0,0,6
62,ESC Pluripotency Pathways WP3931,0.0597444524707284,2.1437800687285224,6.040483947701689,"['WNT5B', 'WNT5A', 'STAT3', 'PDGFB', 'SMAD6', 'FGF2', 'MAP2K6']",0.34744139442693145,0,0,7
63,Immune response to tuberculosis WP4197,0.06095871492663969,3.818259385665529,10.681803802649277,"['IFNAR2', 'OAS1', 'PTPN2']",0.34744139442693145,0,0,3
64,Vitamin B12 metabolism WP1533,0.06095871492663969,3.818259385665529,10.681803802649277,"['PLAT', 'APOE', 'RELA']",0.34744139442693145,0,0,3
65,White fat cell differentiation WP4149,0.06095871492663969,3.818259385665529,10.681803802649277,"['STAT5A', 'CEBPA', 'CEBPD']",0.34744139442693145,0,0,3
66,Hepatitis B infection WP4666,0.06162301213141774,1.7763066836641777,4.950069192115436,"['STAT5A', 'SRC', 'STAT3', 'IRF7', 'IKBKE', 'JAK3', 'TLR3', 'RELA', 'MAP2K6', 'CREB5', 'TLR2']",0.34744139442693145,0,0,11
67,"COVID-19, thrombosis and anticoagulation WP4927",0.061668706950667056,inf,inf,['F13A1'],0.34744139442693145,0,0,1
68,SCFA and skeletal muscle substrate metabolism WP4030,0.061668706950667056,inf,inf,['PPARD'],0.34744139442693145,0,0,1
69,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.06483019504432236,6.103577512776831,16.699289265663044,"['CASP1', 'RELA']",0.34744139442693145,0,0,2
70,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.06483019504432236,6.103577512776831,16.699289265663044,"['NOTCH1', 'SRC']",0.34744139442693145,0,0,2
71,Caloric restriction and aging WP4191,0.06483019504432236,6.103577512776831,16.699289265663044,"['NAMPT', 'IGF1']",0.34744139442693145,0,0,2
72,Differentiation of white and brown adipocyte WP2895,0.06483019504432236,6.103577512776831,16.699289265663044,"['PLAC8', 'CEBPA']",0.34744139442693145,0,0,2
73,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.06483019504432236,6.103577512776831,16.699289265663044,"['SPP1', 'ENPP1']",0.34744139442693145,0,0,2
74,"GPCRs, Class B Secretin-like WP334",0.06483019504432236,6.103577512776831,16.699289265663044,"['ADGRE2', 'CALCR']",0.34744139442693145,0,0,2
75,Platelet-mediated interactions with vascular and circulating cells WP4462,0.06483019504432236,6.103577512776831,16.699289265663044,"['SELPLG', 'TLR2']",0.34744139442693145,0,0,2
76,Transcriptional cascade regulating adipogenesis WP4211,0.06483019504432236,6.103577512776831,16.699289265663044,"['CEBPA', 'CEBPD']",0.34744139442693145,0,0,2
77,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.0652511887094481,1.9765698739659097,5.395069243254902,"['NOTCH1', 'WNT5B', 'WNT5A', 'PROX1', 'RBPJ', 'HIF1A', 'MAP2K6', 'EZH2']",0.34744139442693145,0,0,8
78,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.07171046787933114,3.524153321081649,9.286561777110293,"['BCL6', 'DUSP6', 'EZH2']",0.36751614788157205,0,0,3
79,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.07171046787933114,3.524153321081649,9.286561777110293,"['CEBPA', 'PTPN1', 'TNFRSF11A']",0.36751614788157205,0,0,3
80,SARS coronavirus and innate immunity WP4912,0.07171046787933114,3.524153321081649,9.286561777110293,"['IFNAR2', 'IKBKE', 'TLR3']",0.36751614788157205,0,0,3
81,Fatty acid beta-oxidation WP143,0.07278106307558305,2.7785547785547786,7.28064564196929,"['CPT1A', 'LIPC', 'GK', 'ACSL1']",0.3683979735924574,0,0,4
82,Oncostatin M Signaling Pathway WP2374,0.07912518720778838,2.13466831544936,5.41506441731357,"['SRC', 'PXN', 'STAT3', 'JAK3', 'HIF1A', 'RELA']",0.38347904606363403,0,0,6
83,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.08015824995609168,1.9840906198294515,5.007353609976418,"['WNT5A', 'STAT3', 'NRG1', 'IGF1', 'FGF2', 'IKBKE', 'MAP2K6']",0.38347904606363403,0,0,7
84,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.08207394235381374,2.3165732669157326,5.791745214377318,"['HSPA5', 'HSPB1', 'NRG1', 'APOE', 'YBX3']",0.38347904606363403,0,0,5
85,Development and heterogeneity of the ILC family WP3893,0.08299266850131069,5.085746734809767,12.658438912712635,"['NFIL3', 'IL15']",0.38347904606363403,0,0,2
86,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.08299266850131069,5.085746734809767,12.658438912712635,"['STAT3', 'TCF4']",0.38347904606363403,0,0,2
87,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.08299266850131069,5.085746734809767,12.658438912712635,"['STAT3', 'HMOX1']",0.38347904606363403,0,0,2
88,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.08299266850131069,5.085746734809767,12.658438912712635,"['ABCB4', 'PPARD']",0.38347904606363403,0,0,2
89,Vitamin D in inflammatory diseases WP4482,0.08324301243820348,3.27206240858118,8.134317988161424,"['DUSP1', 'RELA', 'MAP2K6']",0.38347904606363403,0,0,3
90,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.09305745954446301,1.5342608695652173,3.6431609392980753,"['IFNAR2', 'IL4R', 'ANGPT2', 'PDGFB', 'IGF1', 'HIF1A', 'FGF2', 'GNG10', 'PIK3IP1', 'IL3RA', 'SPP1', 'ITGAX', 'JAK3', 'CREB5']",0.41739622093986306,0,0,14
91,Apoptosis WP254,0.09900809383426203,1.9947796256245804,4.613034956622009,"['CASP4', 'CASP1', 'IRF7', 'IGF1', 'TNFRSF1B', 'RELA']",0.41739622093986306,0,0,6
92,Cell Differentiation - Index expanded WP2023,0.10247299482789891,4.358724750547578,9.92985485655091,"['STAT3', 'EZH2']",0.41739622093986306,0,0,2
93,LTF danger signal response pathway WP4478,0.10247299482789891,4.358724750547578,9.92985485655091,"['CD14', 'TLR2']",0.41739622093986306,0,0,2
94,NOTCH1 regulation of endothelial cell calcification WP3413,0.10247299482789891,4.358724750547578,9.92985485655091,"['NOTCH1', 'PLAT']",0.41739622093986306,0,0,2
95,Omega-3/Omega-6 FA synthesis WP4723,0.10247299482789891,4.358724750547578,9.92985485655091,"['ACSL1', 'ELOVL5']",0.41739622093986306,0,0,2
96,Pyrimidine metabolism and related diseases WP4225,0.10247299482789891,4.358724750547578,9.92985485655091,"['DPYD', 'TYMP']",0.41739622093986306,0,0,2
97,Tryptophan catabolism leading to NAD+ production WP4210,0.10247299482789891,4.358724750547578,9.92985485655091,"['HAAO', 'NAMPT']",0.41739622093986306,0,0,2
98,PI3K-Akt signaling pathway WP4172,0.10468287226996503,1.501562785041046,3.3887565688495243,"['IFNAR2', 'IL4R', 'ANGPT2', 'PDGFB', 'IGF1', 'FGF2', 'RELA', 'GNG10', 'IL3RA', 'SPP1', 'PIK3AP1', 'JAK3', 'TLR2', 'CREB5']",0.41739622093986306,0,0,14
99,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.10846180171385261,2.8624146757679183,6.358445523612004,"['SCO2', 'NAMPT', 'RELA']",0.41739622093986306,0,0,3
100,Osteoblast differentiation WP4787,0.11359618942308108,1.9112349914236706,4.157137392013182,"['NOTCH1', 'WNT5B', 'WNT5A', 'PRKCQ', 'RBPJ', 'FGF2']",0.41739622093986306,0,0,6
101,TNF-alpha signaling pathway WP231,0.1174292815198683,1.784478808705613,3.8222090404693936,"['TNFAIP3', 'MAP3K8', 'PYGL', 'KSR2', 'TNFRSF1B', 'NSMAF', 'MAP2K6']",0.41739622093986306,0,0,7
102,Blood Clotting Cascade WP272,0.11954055917836283,15.239795918367347,32.370843771865836,['PLAT'],0.41739622093986306,0,0,1
103,Composition of Lipid Particles WP3601,0.11954055917836283,15.239795918367347,32.370843771865836,['APOE'],0.41739622093986306,0,0,1
104,GABA metabolism (aka GHB) WP4157,0.11954055917836283,15.239795918367347,32.370843771865836,['ADHFE1'],0.41739622093986306,0,0,1
105,Gene regulatory network modelling somitogenesis  WP2854,0.11954055917836283,15.239795918367347,32.370843771865836,['NOTCH1'],0.41739622093986306,0,0,1
106,Hfe effect on hepcidin production WP3924,0.11954055917836283,15.239795918367347,32.370843771865836,['HAMP'],0.41739622093986306,0,0,1
107,Osteoblast Signaling WP322,0.11954055917836283,15.239795918367347,32.370843771865836,['PDGFB'],0.41739622093986306,0,0,1
108,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.11954055917836283,15.239795918367347,32.370843771865836,['HRH2'],0.41739622093986306,0,0,1
109,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.11954055917836283,15.239795918367347,32.370843771865836,['NOTCH1'],0.41739622093986306,0,0,1
110,EPO Receptor Signaling WP581,0.12204755657187194,2.6937361975506926,5.665855221598026,"['STAT5A', 'SRC', 'STAT3']",0.41739622093986306,0,0,3
111,IL-7 signaling pathway WP205,0.12204755657187194,2.6937361975506926,5.665855221598026,"['STAT5A', 'STAT3', 'JAK3']",0.41739622093986306,0,0,3
112,IL17 signaling pathway WP2112,0.12204755657187194,2.6937361975506926,5.665855221598026,"['CEBPD', 'STAT3', 'RELA']",0.41739622093986306,0,0,3
113,Autosomal recessive Osteopetrosis pathways WP4788,0.1230401878390189,3.8134582623509368,7.990126483748301,"['TNFRSF11A', 'TCIRG1']",0.41739622093986306,0,0,2
114,Biomarkers for pyrimidine metabolism disorders WP4584,0.1230401878390189,3.8134582623509368,7.990126483748301,"['DPYD', 'TYMP']",0.41739622093986306,0,0,2
115,Development of ureteric collection system WP5053,0.1230401878390189,3.8134582623509368,7.990126483748301,"['ROBO2', 'SALL1']",0.41739622093986306,0,0,2
116,Iron metabolism in placenta WP2007,0.1230401878390189,3.8134582623509368,7.990126483748301,"['STEAP3', 'HAMP']",0.41739622093986306,0,0,2
117,"NAD metabolism, sirtuins and aging WP3630",0.1230401878390189,3.8134582623509368,7.990126483748301,"['NAMPT', 'HIF1A']",0.41739622093986306,0,0,2
118,Osteopontin Signaling WP1434,0.1230401878390189,3.8134582623509368,7.990126483748301,"['SPP1', 'RELA']",0.41739622093986306,0,0,2
119,PPAR-alpha pathway WP2878,0.1230401878390189,3.8134582623509368,7.990126483748301,"['CPT1A', 'PLTP']",0.41739622093986306,0,0,2
120,RANKL/RANK signaling pathway WP2018,0.12318278715542301,2.0106344628695023,4.210441383887705,"['CALCR', 'SRC', 'TNFRSF11A', 'RELA', 'MAP2K6']",0.41739622093986306,0,0,5
121,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.12318278715542301,2.0106344628695023,4.210441383887705,"['MKNK2', 'IRF7', 'MAP3K8', 'RELA', 'MAP2K6']",0.41739622093986306,0,0,5
122,Regulation of Actin Cytoskeleton WP51,0.13065086155427924,1.601523656776263,3.2594636952111036,"['GNA13', 'CHRM3', 'PXN', 'PDGFB', 'IQGAP1', 'CD14', 'PFN1', 'SSH2', 'FGF2']",0.4390725675184794,0,0,9
123,The influence of laminopathies on Wnt signaling WP4844,0.13621472958136674,2.5437997724687142,5.071122703636503,"['CEBPA', 'CEBPD', 'SPP1']",0.45038741232548685,0,0,3
124,Unfolded protein response WP4925,0.13621472958136674,2.5437997724687142,5.071122703636503,"['XBP1', 'HSPA5', 'TXNIP']",0.45038741232548685,0,0,3
125,3q29 copy number variation syndrome WP4906,0.14186005127203688,1.9096746575342465,3.729430874060841,"['STAT5A', 'PXN', 'HIF1A', 'HAMP', 'PIGX']",0.45221014461806397,0,0,5
126,Microglia Pathogen Phagocytosis Pathway WP3937,0.14314191741242116,2.1062186855290306,4.094317913094456,"['C1QB', 'C1QA', 'FCER1G', 'C1QC']",0.45221014461806397,0,0,4
127,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.14314191741242116,2.1062186855290306,4.094317913094456,"['CEBPA', 'NOTCH1', 'CEBPD', 'SPP1']",0.45221014461806397,0,0,4
128,Eicosanoid Synthesis WP167,0.14448665596333263,3.3893621048646603,6.556951881878701,"['LTC4S', 'ALOX15B']",0.45221014461806397,0,0,2
129,IL1 and megakaryocytes in obesity WP2865,0.14448665596333263,3.3893621048646603,6.556951881878701,"['S100A9', 'TLR2']",0.45221014461806397,0,0,2
130,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.14448665596333263,3.3893621048646603,6.556951881878701,"['IL4R', 'STAT3']",0.45221014461806397,0,0,2
131,Omega-9 FA synthesis WP4724,0.14448665596333263,3.3893621048646603,6.556951881878701,"['ACSL1', 'ELOVL5']",0.45221014461806397,0,0,2
132,SARS-CoV-2 mitochondrial interactions WP5038,0.15091034677454052,2.409646128974313,4.556807935149649,"['IRF7', 'IKBKE', 'TLR3']",0.46677356528096065,0,0,3
133,Cardiac Hypertrophic Response WP2795,0.15163357429305996,1.8628884062813231,3.5139447241632884,"['NRG1', 'IGF1', 'FGF2', 'IKBKE', 'MAP2K6']",0.46677356528096065,0,0,5
134,Ferroptosis WP4313,0.15483220702002598,2.0357834757834756,3.7975775386307338,"['STEAP3', 'ACSL1', 'HMOX1', 'FTL']",0.46677356528096065,0,0,4
135,Interleukin-11 Signaling Pathway WP2332,0.15483220702002598,2.0357834757834756,3.7975775386307338,"['SRC', 'FES', 'STAT3', 'RELA']",0.46677356528096065,0,0,4
136,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.15483220702002598,2.0357834757834756,3.7975775386307338,"['WNT5B', 'WNT5A', 'ROR2', 'EZH2']",0.46677356528096065,0,0,4
137,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1660814255112845,2.2889078498293514,4.109223837105263,"['SLC16A1', 'ANGPT2', 'HIF1A']",0.4852122761141238,0,0,3
138,Canonical and non-canonical Notch signaling WP3845,0.16662620307533021,3.050085178875639,5.4657595955088425,"['NOTCH1', 'RBPJ']",0.4852122761141238,0,0,2
139,Imatinib and Chronic Myeloid Leukemia WP3640,0.16662620307533021,3.050085178875639,5.4657595955088425,"['NOP2', 'PIM1']",0.4852122761141238,0,0,2
140,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.16662620307533021,3.050085178875639,5.4657595955088425,"['CPT1A', 'ACSL1']",0.4852122761141238,0,0,2
141,Neural Crest Differentiation WP2064,0.16686568520022307,1.9698924731182796,3.527222624722508,"['NOTCH1', 'TCF4', 'RBPJ', 'FGF2']",0.4852122761141238,0,0,4
142,AGE/RAGE pathway WP2324,0.17198666855035769,1.775844217903791,3.1260866157624383,"['STAT5A', 'SRC', 'STAT3', 'HIF1A', 'RELA']",0.49157261792860546,0,0,5
143,Dopaminergic Neurogenesis WP2855,0.1738488526820678,7.619047619047619,13.330049676346372,['STAT3'],0.49157261792860546,0,0,1
144,EV release from cardiac cells and their functional effects WP3297,0.1738488526820678,7.619047619047619,13.330049676346372,['CXCL12'],0.49157261792860546,0,0,1
145,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.1738488526820678,7.619047619047619,13.330049676346372,['ELOVL5'],0.49157261792860546,0,0,1
146,Metapathway biotransformation Phase I and II WP702,0.18253911162895448,1.7352895392278953,2.951364515975021,"['NDST3', 'FMO4', 'FMO5', 'GAL3ST4', 'HS3ST1']",0.512609834026516,0,0,5
147,Gastric Cancer Network 1 WP2361,0.18929218625882033,2.772494966702803,4.614716672255502,"['NOTCH1', 'ECT2']",0.5173986424407756,0,0,2
148,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.18929218625882033,2.772494966702803,4.614716672255502,"['TLR5', 'TLR2']",0.5173986424407756,0,0,2
149,Transcription factor regulation in adipogenesis WP3599,0.18929218625882033,2.772494966702803,4.614716672255502,"['CEBPA', 'CEBPD']",0.5173986424407756,0,0,2
150,Wnt signaling in kidney disease WP4150,0.18929218625882033,2.772494966702803,4.614716672255502,"['WNT5B', 'WNT5A']",0.5173986424407756,0,0,2
151,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.19107700019116894,1.6078360566940508,2.6610953549315624,"['SRC', 'STAT3', 'PDGFB', 'NRG1', 'IGF1', 'FGF2']",0.5175309921473547,0,0,6
152,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.19186514830828758,1.85009065009065,3.0544302965197208,"['PPP1R14B', 'XBP1', 'HSPA5', 'PPP1R3B']",0.5175309921473547,0,0,4
153,Kit receptor signaling pathway WP304,0.1933233394335258,1.6965372907153728,2.7880743828316827,"['STAT5A', 'SRC', 'STAT3', 'SOCS6', 'SH2B2']",0.5180560076323241,0,0,5
154,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.21233581881252503,2.541169789892107,3.9377616550278947,"['PXN', 'PRKCQ']",0.5616624884718404,0,0,2
155,Triacylglyceride synthesis WP325,0.21233581881252503,2.541169789892107,3.9377616550278947,"['LIPC', 'GK']",0.5616624884718404,0,0,2
156,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.2139267633872397,1.9896868971657515,3.0683390412666687,"['CASP1', 'PRDM1', 'RELA']",0.5622434165946685,0,0,3
157,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.21794312840161684,1.743980463980464,2.6569910856459207,"['RYR2', 'CACNB4', 'SGCB', 'CTNNA3']",0.5689702981803969,0,0,4
158,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.22481265440298606,5.078798185941043,7.580044690345127,['HIF1A'],0.5689702981803969,0,0,1
159,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.22481265440298606,5.078798185941043,7.580044690345127,['HIF1A'],0.5689702981803969,0,0,1
160,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.22481265440298606,5.078798185941043,7.580044690345127,['SRC'],0.5689702981803969,0,0,1
161,Role of Osx and miRNAs in tooth development WP3971,0.22481265440298606,5.078798185941043,7.580044690345127,['NOTCH1'],0.5689702981803969,0,0,1
162,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.22481265440298606,5.078798185941043,7.580044690345127,['STAT3'],0.5689702981803969,0,0,1
163,Cytosolic DNA-sensing pathway WP4655,0.23132438121284624,1.695346628679962,2.4818760899798673,"['CASP1', 'IRF7', 'IKBKE', 'RELA']",0.5748060381652543,0,0,4
164,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.23132438121284624,1.695346628679962,2.4818760899798673,"['WNT5B', 'WNT5A', 'ROR2', 'EZH2']",0.5748060381652543,0,0,4
165,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.23132438121284624,1.695346628679962,2.4818760899798673,"['CXCL12', 'IRF7', 'IKBKE', 'RELA']",0.5748060381652543,0,0,4
166,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.23562460770712465,2.3454331018215173,3.3903596347771874,"['MKNK2', 'MAP2K6']",0.5784795758079109,0,0,2
167,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.23562460770712465,2.3454331018215173,3.3903596347771874,"['STK38', 'EZH2']",0.5784795758079109,0,0,2
168,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.23848372373477794,1.5573455409561086,2.232383530332781,"['GNA13', 'SRC', 'PDE4D', 'STAT3', 'MAP2K6']",0.5820138495908271,0,0,5
169,Chemokine signaling pathway WP3929,0.24818950108735718,1.372759094161558,1.9130258797557458,"['FGR', 'CX3CR1', 'GNG10', 'CXCL12', 'PXN', 'STAT3', 'JAK3', 'RELA']",0.6021165410995056,0,0,8
170,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.25020450582751874,1.526027397260274,2.114275360055212,"['HSPA5', 'HSPA6', 'CASP1', 'HSPA1B', 'HSPA1A']",0.6034343964075451,0,0,5
171,Fluoropyrimidine Activity WP1601,0.2590409152632618,2.1776587977610125,2.941514553572088,"['DPYD', 'TYMP']",0.6139119957106204,0,0,2
172,Gastric Cancer Network 2 WP2363,0.2590409152632618,2.1776587977610125,2.941514553572088,"['PLAC8', 'RNF144B']",0.6139119957106204,0,0,2
173,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2590409152632618,2.1776587977610125,2.941514553572088,"['P3H2', 'TNFRSF11A']",0.6139119957106204,0,0,2
174,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.26422754213255184,1.759516933578367,2.3418196406083123,"['IFNAR2', 'OAS1', 'IKBKE']",0.617576876413499,0,0,3
175,IL-3 signaling pathway WP286,0.2725418685154508,1.564409379793995,2.0336743586952744,"['STAT5A', 'SRC', 'IL3RA', 'STAT3']",0.617576876413499,0,0,4
176,Pathogenic Escherichia coli infection WP2272,0.2725418685154508,1.564409379793995,2.0336743586952744,"['HCLS1', 'LY96', 'CD14', 'TLR5']",0.617576876413499,0,0,4
177,Ketogenesis and Ketolysis WP4742,0.27263759666059345,3.808673469387755,4.949797175293134,['SLC16A1'],0.617576876413499,0,0,1
178,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.27263759666059345,3.808673469387755,4.949797175293134,['STAT5A'],0.617576876413499,0,0,1
179,NAD Biosynthesis II (from tryptophan) WP2485,0.27263759666059345,3.808673469387755,4.949797175293134,['HAAO'],0.617576876413499,0,0,1
180,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.27263759666059345,3.808673469387755,4.949797175293134,['RELA'],0.617576876413499,0,0,1
181,Thiamine metabolic pathways WP4297,0.27263759666059345,3.808673469387755,4.949797175293134,['SLC25A19'],0.617576876413499,0,0,1
182,NRF2-ARE regulation WP4357,0.2824806358344309,2.032254400908575,2.569064801481416,"['SRC', 'HMOX1']",0.6328801130716757,0,0,2
183,Nuclear receptors WP170,0.2824806358344309,2.032254400908575,2.569064801481416,"['NR1D2', 'PPARD']",0.6328801130716757,0,0,2
184,Wnt signaling pathway and pluripotency WP399,0.28615783741103085,1.4391638666322046,1.8006987276309445,"['WNT5B', 'LRRK2', 'WNT5A', 'PRKCQ', 'PPARD']",0.6376343116224057,0,0,5
185,CAMKK2  Pathway WP4874,0.29851360214797623,1.6334714773281327,1.9747686465633583,"['CHRM3', 'HMOX1', 'RELA']",0.650909217597524,0,0,3
186,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.29851360214797623,1.6334714773281327,1.9747686465633583,"['BST2', 'IFITM2', 'MAP2K6']",0.650909217597524,0,0,3
187,Phosphodiesterases in neuronal function WP4222,0.29851360214797623,1.6334714773281327,1.9747686465633583,"['PDE4D', 'PDE4B', 'PDE5A']",0.650909217597524,0,0,3
188,TGF-beta Receptor Signaling WP560,0.29851360214797623,1.6334714773281327,1.9747686465633583,"['STAT3', 'SPP1', 'SMAD6']",0.650909217597524,0,0,3
189,Interferon type I signaling pathways WP585,0.30067576419048003,1.4877631853241609,1.7878789262329935,"['IFNAR2', 'STAT5A', 'STAT3', 'MAP2K6']",0.650909217597524,0,0,4
190,Purinergic signaling WP4900,0.3058519788905297,1.9050255536626917,2.256796186407872,"['P2RY12', 'P2RY13']",0.650909217597524,0,0,2
191,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.31575793034528227,1.5769683417676827,1.8178966222598458,"['IFNAR2', 'CXCL12', 'IRF7']",0.650909217597524,0,0,3
192,Signaling of Hepatocyte Growth Factor Receptor WP313,0.31575793034528227,1.5769683417676827,1.8178966222598458,"['SRC', 'PXN', 'STAT3']",0.650909217597524,0,0,3
193,Canonical NF-KB pathway WP4562,0.3175166915109873,3.0465986394557825,3.4951337900690502,['RELA'],0.650909217597524,0,0,1
194,Cell Differentiation - Index WP2029,0.3175166915109873,3.0465986394557825,3.4951337900690502,['STAT3'],0.650909217597524,0,0,1
195,Cells and molecules involved in local acute inflammatory response  WP4493,0.3175166915109873,3.0465986394557825,3.4951337900690502,['SELPLG'],0.650909217597524,0,0,1
196,HIF1A and PPARG regulation of glycolysis WP2456,0.3175166915109873,3.0465986394557825,3.4951337900690502,['HIF1A'],0.650909217597524,0,0,1
197,Major receptors targeted by epinephrine and norepinephrine WP4589,0.3175166915109873,3.0465986394557825,3.4951337900690502,['ADRB2'],0.650909217597524,0,0,1
198,Nanomaterial-induced inflammasome activation WP3890,0.3175166915109873,3.0465986394557825,3.4951337900690502,['CASP1'],0.650909217597524,0,0,1
199,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3175166915109873,3.0465986394557825,3.4951337900690502,['IL4R'],0.650909217597524,0,0,1
200,Supression of HMGB1 mediated inflammation by THBD WP4479,0.3175166915109873,3.0465986394557825,3.4951337900690502,['RELA'],0.650909217597524,0,0,1
201,Nanoparticle triggered autophagic cell death WP2509,0.32907434998929047,1.7927648060927948,1.9926071063878743,"['VMP1', 'ATG14']",0.6679231856218272,0,0,2
202,Photodynamic therapy-induced unfolded protein response WP3613,0.32907434998929047,1.7927648060927948,1.9926071063878743,"['XBP1', 'HSPA5']",0.6679231856218272,0,0,2
203,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.33301952913430355,1.5242320819112627,1.6759757031080877,"['CH25H', 'ACSL1', 'ELOVL5']",0.669303955613061,0,0,3
204,IL-2 signaling pathway WP49,0.33301952913430355,1.5242320819112627,1.6759757031080877,"['STAT5A', 'STAT3', 'JAK3']",0.669303955613061,0,0,3
205,Ebola Virus Pathway on Host WP4217,0.34956108494830185,1.241348997043075,1.3047533232507156,"['BST2', 'NPC2', 'RASA2', 'IRF7', 'IQGAP1', 'IKBKE', 'RELA']",0.6776107635050039,0,0,7
206,miRNAs involvement in the immune response in sepsis WP4329,0.3520773231720382,1.6929774749195532,1.767306735741015,"['IRF7', 'RELA']",0.6776107635050039,0,0,2
207,Nanoparticle-mediated activation of receptor signaling WP2643,0.3520773231720382,1.6929774749195532,1.767306735741015,"['SRC', 'PXN']",0.6776107635050039,0,0,2
208,Type II interferon signaling (IFNG) WP619,0.3520773231720382,1.6929774749195532,1.767306735741015,"['OAS1', 'PSMB9']",0.6776107635050039,0,0,2
209,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.35963110224197653,2.5385487528344672,2.596114125467659,['SMAD6'],0.6776107635050039,0,0,1
210,"Cerebral organic acidurias, including diseases WP4519",0.35963110224197653,2.5385487528344672,2.596114125467659,['ADHFE1'],0.6776107635050039,0,0,1
211,Cytokines and Inflammatory Response WP530,0.35963110224197653,2.5385487528344672,2.596114125467659,['IL15'],0.6776107635050039,0,0,1
212,Dual hijack model of Vif in HIV infection WP3300,0.35963110224197653,2.5385487528344672,2.596114125467659,['RUNX1'],0.6776107635050039,0,0,1
213,Estrogen Receptor Pathway WP2881,0.35963110224197653,2.5385487528344672,2.596114125467659,['STAT3'],0.6776107635050039,0,0,1
214,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.35963110224197653,2.5385487528344672,2.596114125467659,['PRKCQ'],0.6776107635050039,0,0,1
215,Genes targeted by miRNAs in adipocytes WP1992,0.35963110224197653,2.5385487528344672,2.596114125467659,['IGF1'],0.6776107635050039,0,0,1
216,LDLRAD4 and what we know about it WP4904,0.35963110224197653,2.5385487528344672,2.596114125467659,['PMEPA1'],0.6776107635050039,0,0,1
217,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.35963110224197653,2.5385487528344672,2.596114125467659,['BUB3'],0.6776107635050039,0,0,1
218,T-cell receptor (TCR) signaling pathway WP69,0.3602906010831484,1.2919375435337823,1.3188671391977091,"['IL15RA', 'MAP3K8', 'PRKCQ', 'OPRM1', 'RELA']",0.6776107635050039,0,0,5
219,G13 Signaling Pathway WP524,0.36745699811760185,1.4286476109215016,1.4302890971685267,"['GNA13', 'IQGAP1', 'PFN1']",0.6817075530688541,0,0,3
220,PDGF Pathway WP2526,0.36745699811760185,1.4286476109215016,1.4302890971685267,"['SRC', 'STAT3', 'PDGFB']",0.6817075530688541,0,0,3
221,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.36745699811760185,1.4286476109215016,1.4302890971685267,"['STAT3', 'SPP1', 'SMAD6']",0.6817075530688541,0,0,3
222,Aryl Hydrocarbon Receptor Pathway WP2873,0.37479969646186867,1.603694073343495,1.5738068904640259,"['SLC7A5', 'SRC']",0.6829683357749606,0,0,2
223,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.37479969646186867,1.603694073343495,1.5738068904640259,"['HSPB1', 'LITAF']",0.6829683357749606,0,0,2
224,Melatonin metabolism and effects WP3298,0.37479969646186867,1.603694073343495,1.5738068904640259,"['PER3', 'APOE']",0.6829683357749606,0,0,2
225,TLR4 Signaling and Tolerance WP3851,0.37479969646186867,1.603694073343495,1.5738068904640259,"['IRF7', 'IKBKE']",0.6829683357749606,0,0,2
226,Glycerophospholipid Biosynthetic Pathway WP2533,0.3971886254135192,1.5233390119250425,1.4065659124756542,"['PGS1', 'GK']",0.6934400693506432,0,0,2
227,Signal transduction through IL1R WP4496,0.3971886254135192,1.5233390119250425,1.4065659124756542,"['RELA', 'MAP2K6']",0.6934400693506432,0,0,2
228,Senescence and Autophagy in Cancer WP615,0.3977128500130999,1.229010163499779,1.133178116243309,"['SRC', 'IRF7', 'PLAT', 'IGF1', 'ATG14']",0.6934400693506432,0,0,5
229,Biotin Metabolism (including IEMs) WP5031,0.3991508691871995,2.175655976676385,1.99815685762571,['BTD'],0.6934400693506432,0,0,1
230,BMP Signaling Pathway in Eyelid Development WP3927,0.3991508691871995,2.175655976676385,1.99815685762571,['NOTCH1'],0.6934400693506432,0,0,1
231,Fatty acid transporters WP5061,0.3991508691871995,2.175655976676385,1.99815685762571,['ACSL1'],0.6934400693506432,0,0,1
232,Leptin and adiponectin WP3934,0.3991508691871995,2.175655976676385,1.99815685762571,['CPT1A'],0.6934400693506432,0,0,1
233,Nanoparticle triggered regulated necrosis WP2513,0.3991508691871995,2.175655976676385,1.99815685762571,['FTL'],0.6934400693506432,0,0,1
234,NLR Proteins WP288,0.3991508691871995,2.175655976676385,1.99815685762571,['RELA'],0.6934400693506432,0,0,1
235,RalA downstream regulated genes WP2290,0.3991508691871995,2.175655976676385,1.99815685762571,['YBX3'],0.6934400693506432,0,0,1
236,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.3991508691871995,2.175655976676385,1.99815685762571,['STAT3'],0.6934400693506432,0,0,1
237,Exercise-induced Circadian Regulation WP410,0.40157294333110644,1.344308371812889,1.22650136630125,"['BTG1', 'NR1D2', 'ERC2']",0.6947042479567664,0,0,3
238,Gastrin signaling pathway WP4659,0.40548289234327384,1.1875431600989061,1.0719674166001067,"['SRC', 'PXN', 'STAT3', 'PRKCQ', 'TCF4', 'RELA']",0.6985209489947155,0,0,6
239,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.41466660698420693,1.2437467294610152,1.0948459161191268,"['NOTCH1', 'SRC', 'PRKCQ', 'MGLL']",0.7096402110867074,0,0,4
240,Circadian rhythm related genes WP3594,0.4153991479531946,1.1395113162932102,1.0010782611353808,"['CPT1A', 'PER3', 'NFIL3', 'NAMPT', 'NR1D2', 'PROX1', 'TNFRSF11A', 'EZH2']",0.7096402110867074,0,0,8
241,Bladder cancer WP2828,0.4191988279655509,1.4506368134988237,1.2611980676882208,"['SRC', 'TYMP']",0.7102128903548589,0,0,2
242,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4191988279655509,1.4506368134988237,1.2611980676882208,"['VMP1', 'PRDM1']",0.7102128903548589,0,0,2
243,15q11.2 copy number variation syndrome WP4940,0.4362355913138573,1.903486394557823,1.5790806037995353,['TUBGCP5'],0.721195937252748,0,0,1
244,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4362355913138573,1.903486394557823,1.5790806037995353,['RYR2'],0.721195937252748,0,0,1
245,Leptin Insulin Overlap WP3935,0.4362355913138573,1.903486394557823,1.5790806037995353,['STAT3'],0.721195937252748,0,0,1
246,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4362355913138573,1.903486394557823,1.5790806037995353,['PRKCQ'],0.721195937252748,0,0,1
247,Overview of nanoparticle effects WP3287,0.4362355913138573,1.903486394557823,1.5790806037995353,['HMOX1'],0.721195937252748,0,0,1
248,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.4362355913138573,1.903486394557823,1.5790806037995353,['TCF4'],0.721195937252748,0,0,1
249,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.44079185536727983,1.3845439058386249,1.1341941357197813,"['PRKCQ', 'RELA']",0.7228986428023388,0,0,2
250,Type 2 papillary renal cell carcinoma WP4241,0.44079185536727983,1.3845439058386249,1.1341941357197813,"['PDGFB', 'HIF1A']",0.7228986428023388,0,0,2
251,G Protein Signaling Pathways WP35,0.4472119245249049,1.1540058115400582,0.928654663982229,"['GNA13', 'GNG10', 'PDE4D', 'PDE4B', 'PRKCQ']",0.730505534084506,0,0,5
252,Apoptosis Modulation and Signaling WP1772,0.4566655543031686,1.1715976331360947,0.9183028932744204,"['CASP4', 'CASP1', 'TNFRSF1B', 'HSPA1A']",0.7399401424344383,0,0,4
253,Folate Metabolism WP176,0.46193542392865816,1.3241982075401821,1.0227182303397726,"['PLAT', 'RELA']",0.7399401424344383,0,0,2
254,Selenium Micronutrient Network WP15,0.46799947355375443,1.2022633375246992,0.9128642548070974,"['PLAT', 'ALOX15B', 'RELA']",0.7399401424344383,0,0,3
255,Wnt signaling WP428,0.47044735128988396,1.1493630059667796,0.8667015706928798,"['WNT5B', 'WNT5A', 'PRICKLE2', 'ROR2']",0.7399401424344383,0,0,4
256,Kynurenine Pathway and links to Cellular Senescence WP5044,0.4710350662814351,1.6917989417989419,1.2736247098752072,['HAAO'],0.7399401424344383,0,0,1
257,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.4710350662814351,1.6917989417989419,1.2736247098752072,['MAP2K6'],0.7399401424344383,0,0,1
258,NAD+ metabolism WP3644,0.4710350662814351,1.6917989417989419,1.2736247098752072,['NAMPT'],0.7399401424344383,0,0,1
259,Neuroinflammation WP4919,0.4710350662814351,1.6917989417989419,1.2736247098752072,['RELA'],0.7399401424344383,0,0,1
260,Proteoglycan biosynthesis WP4784,0.4710350662814351,1.6917989417989419,1.2736247098752072,['CHSY1'],0.7399401424344383,0,0,1
261,Urea cycle and metabolism of amino groups WP497,0.4710350662814351,1.6917989417989419,1.2736247098752072,['ARG2'],0.7399401424344383,0,0,1
262,PDGFR-beta pathway WP3972,0.48260280305280984,1.2688813174332765,0.9244578444767291,"['STAT5A', 'STAT3']",0.7539879655117556,0,0,2
263,Breast cancer pathway WP4262,0.48365569495022376,1.103459400436768,0.801533045636343,"['NOTCH1', 'WNT5B', 'WNT5A', 'IGF1', 'FGF2']",0.7539879655117556,0,0,5
264,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.49997053519192297,1.1418941979522184,0.7915680371779199,"['STAT5A', 'SRC', 'PFN1']",0.7620400570458248,0,0,3
265,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.49997053519192297,1.1418941979522184,0.7915680371779199,"['PRKCQ', 'IFI44L', 'TLR2']",0.7620400570458248,0,0,3
266,Prion disease pathway WP3995,0.5027722551809884,1.2179897785349234,0.8375116765543367,"['HSPA5', 'STAT3']",0.7620400570458248,0,0,2
267,7-oxo-C and 7beta-HC pathways WP5064,0.5036898913644354,1.5224489795918368,1.0440871294181098,['NPC2'],0.7620400570458248,0,0,1
268,Cancer immunotherapy by PD-1 blockade WP4585,0.5036898913644354,1.5224489795918368,1.0440871294181098,['STAT3'],0.7620400570458248,0,0,1
269,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5036898913644354,1.5224489795918368,1.0440871294181098,['PPARD'],0.7620400570458248,0,0,1
270,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5036898913644354,1.5224489795918368,1.0440871294181098,['UGCG'],0.7620400570458248,0,0,1
271,Phytochemical activity on NRF2 transcriptional activation WP3,0.5036898913644354,1.5224489795918368,1.0440871294181098,['HMOX1'],0.7620400570458248,0,0,1
272,Insulin Signaling WP481,0.5095674040304748,1.0409403180487518,0.7017948222059951,"['PTPN1', 'XBP1', 'ENPP1', 'FLOT2', 'MAP3K8', 'PRKCQ', 'SH2B2', 'MAP2K6']",0.7680979251929951,0,0,8
273,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5224265232705733,1.171012973397982,0.7603046826915678,"['TSPO', 'RELA']",0.7736462324431189,0,0,2
274,p38 MAPK Signaling Pathway WP400,0.5224265232705733,1.171012973397982,0.7603046826915678,"['HSPB1', 'MAP2K6']",0.7736462324431189,0,0,2
275,Prader-Willi and Angelman Syndrome WP3998,0.5224265232705733,1.171012973397982,0.7603046826915678,"['TUBGCP5', 'GABRG3']",0.7736462324431189,0,0,2
276,Corticotropin-releasing hormone signaling pathway WP2355,0.5241535255781313,1.0682261208576997,0.6900427214548638,"['PRKCQ', 'TCF4', 'TBX19', 'RELA']",0.7736462324431189,0,0,4
277,Airway smooth muscle cell contraction WP4962,0.5343320276463057,1.3838899196042054,0.867336204785658,['ADRB2'],0.7736462324431189,0,0,1
278,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5343320276463057,1.3838899196042054,0.867336204785658,['WNT5A'],0.7736462324431189,0,0,1
279,Kallmann's Syndrome WP5074,0.5343320276463057,1.3838899196042054,0.867336204785658,['PRKCQ'],0.7736462324431189,0,0,1
280,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5343320276463057,1.3838899196042054,0.867336204785658,['OAS1'],0.7736462324431189,0,0,1
281,Pregnane X receptor pathway WP2876,0.5343320276463057,1.3838899196042054,0.867336204785658,['SRC'],0.7736462324431189,0,0,1
282,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.5343320276463057,1.3838899196042054,0.867336204785658,['PPARD'],0.7736462324431189,0,0,1
283,Integrin-mediated Cell Adhesion WP185,0.5371720884202686,1.0496905393457117,0.652316301632579,"['SRC', 'PXN', 'ITGAX', 'MAP2K6']",0.7736462324431189,0,0,4
284,Aryl Hydrocarbon Receptor Netpath WP2586,0.5415523627101833,1.1275159316045176,0.6915230174690711,"['SRC', 'RELA']",0.7736462324431189,0,0,2
285,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5415523627101833,1.1275159316045176,0.6915230174690711,"['STAT3', 'HIF1A']",0.7736462324431189,0,0,2
286,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5415523627101833,1.1275159316045176,0.6915230174690711,"['STAT3', 'GABRG3']",0.7736462324431189,0,0,2
287,Notch Signaling WP268,0.5415523627101833,1.1275159316045176,0.6915230174690711,"['NOTCH1', 'RBPJ']",0.7736462324431189,0,0,2
288,IL-18 signaling pathway WP4754,0.5584282825826271,0.9922038980509745,0.5780868437902292,"['CPT1A', 'NRN1', 'NFKBIZ', 'SPP1', 'TNFAIP2', 'HMOX1', 'HSPB1', 'TNFAIP3', 'RELA']",0.7825931699410781,0,0,9
289,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5601401132550713,1.0871258213677293,0.6300636906010791,"['HSPB1', 'LMNB1']",0.7825931699410781,0,0,2
290,Leptin signaling pathway WP2034,0.5626571024203069,1.0144729344729344,0.583408056646565,"['PTPN1', 'SRC', 'STAT3', 'RELA']",0.7825931699410781,0,0,4
291,Ebstein-Barr virus LMP1 signaling WP262,0.5630853295917513,1.2684240362811792,0.7284864930516552,['RELA'],0.7825931699410781,0,0,1
292,NAD+ biosynthetic pathways WP3645,0.5630853295917513,1.2684240362811792,0.7284864930516552,['NAMPT'],0.7825931699410781,0,0,1
293,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5630853295917513,1.2684240362811792,0.7284864930516552,['BCL2L14'],0.7825931699410781,0,0,1
294,Sleep regulation WP3591,0.5630853295917513,1.2684240362811792,0.7284864930516552,['PER3'],0.7825931699410781,0,0,1
295,Type II diabetes mellitus WP1584,0.5630853295917513,1.2684240362811792,0.7284864930516552,['GK'],0.7825931699410781,0,0,1
296,B Cell Receptor Signaling Pathway WP23,0.5760457112268457,0.9879247464863903,0.5449079350765555,"['BCL6', 'HCLS1', 'PIK3AP1', 'RELA', 'MAP2K6']",0.7906113637217662,0,0,5
297,Amyotrophic lateral sclerosis (ALS) WP2447,0.5781833089768684,1.0495212359748576,0.5749952351564259,"['CASP1', 'MAP2K6']",0.7906113637217662,0,0,2
298,MET in type 1 papillary renal cell carcinoma WP4205,0.5894825138884768,0.9922837216204184,0.5244320900597562,"['SRC', 'STAT3', 'JAK3']",0.7906113637217662,0,0,3
299,Retinoblastoma gene in cancer WP2446,0.5894825138884768,0.9922837216204184,0.5244320900597562,"['RPA3', 'HMGB2', 'SAP30']",0.7906113637217662,0,0,3
300,1q21.1 copy number variation syndrome WP4905,0.5900660421923426,1.1707221350078494,0.6175802917862036,['FMO5'],0.7906113637217662,0,0,1
301,Apoptosis Modulation by HSP70 WP384,0.5900660421923426,1.1707221350078494,0.6175802917862036,['HSPA1A'],0.7906113637217662,0,0,1
302,Heart Development WP1591,0.5900660421923426,1.1707221350078494,0.6175802917862036,['NOTCH1'],0.7906113637217662,0,0,1
303,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5900660421923426,1.1707221350078494,0.6175802917862036,['RAB27A'],0.7906113637217662,0,0,1
304,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5900660421923426,1.1707221350078494,0.6175802917862036,['HMOX1'],0.7906113637217662,0,0,1
305,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5900660421923426,1.1707221350078494,0.6175802917862036,['RELA'],0.7906113637217662,0,0,1
306,Striated Muscle Contraction Pathway WP383,0.5900660421923426,1.1707221350078494,0.6175802917862036,['MYOM1'],0.7906113637217662,0,0,1
307,Cell migration and invasion through p75NTR WP4561,0.6153832678400563,1.086977648202138,0.5277385240048317,['STAT3'],0.7986324307374513,0,0,1
308,DNA Mismatch Repair WP531,0.6153832678400563,1.086977648202138,0.5277385240048317,['RPA3'],0.7986324307374513,0,0,1
309,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6153832678400563,1.086977648202138,0.5277385240048317,['HIF1A'],0.7986324307374513,0,0,1
310,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6153832678400563,1.086977648202138,0.5277385240048317,['ANGPT2'],0.7986324307374513,0,0,1
311,Overview of interferons-mediated signaling pathway WP4558,0.6153832678400563,1.086977648202138,0.5277385240048317,['IFNAR2'],0.7986324307374513,0,0,1
312,Oxysterols derived from cholesterol WP4545,0.6153832678400563,1.086977648202138,0.5277385240048317,['CH25H'],0.7986324307374513,0,0,1
313,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.6153832678400563,1.086977648202138,0.5277385240048317,['RELA'],0.7986324307374513,0,0,1
314,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6153832678400563,1.086977648202138,0.5277385240048317,['SRC'],0.7986324307374513,0,0,1
315,Sphingolipid Metabolism (general overview) WP4725,0.6153832678400563,1.086977648202138,0.5277385240048317,['UGCG'],0.7986324307374513,0,0,1
316,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.61553133686106,0.9418696590943648,0.45706054488023334,"['STAT5A', 'SRC', 'STAT3', 'SPP1', 'YBX1', 'RELA', 'SH2B2']",0.7986324307374513,0,0,7
317,Sphingolipid Metabolism (integrated pathway) WP4726,0.6391394045184702,1.0143990929705216,0.45407819265295324,['UGCG'],0.8266471793456555,0,0,1
318,Non-small cell lung cancer WP4255,0.64311513145955,0.9124914675767918,0.40280249294701603,"['STAT5A', 'STAT3', 'JAK3']",0.8269076728270378,0,0,3
319,IL-6 signaling pathway WP364,0.6448739447432129,0.9218935522172319,0.40443508467442213,"['STAT3', 'PRDM1']",0.8269076728270378,0,0,2
320,Androgen receptor signaling pathway WP138,0.6453913544015905,0.9077688480673556,0.3975105217586597,"['SRC', 'LIMK2', 'STAT3', 'RELA']",0.8269076728270378,0,0,4
321,Pyrimidine metabolism WP4022,0.6557241735586272,0.8944990965669545,0.3774920770227292,"['DPYD', 'ENPP1', 'TYMP']",0.833251447901447,0,0,3
322,Thermogenesis WP4321,0.6563295813412116,0.8943187531422826,0.376590656290581,"['CPT1A', 'ACSL1', 'MGLL', 'CREB5']",0.833251447901447,0,0,4
323,IL-5 signaling pathway WP127,0.6601859504598474,0.8946788255336207,0.371500835292893,"['STAT5A', 'STAT3']",0.833251447901447,0,0,2
324,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6601859504598474,0.8946788255336207,0.371500835292893,"['ATG14', 'FTL']",0.833251447901447,0,0,2
325,Tryptophan metabolism WP465,0.6614305568414144,0.9508928571428571,0.3930518280440509,['HAAO'],0.833251447901447,0,0,1
326,Focal Adhesion WP306,0.6625365171118822,0.8939562102714156,0.3680235372718598,"['FGR', 'SRC', 'PXN', 'PDGFB', 'SPP1', 'IGF1']",0.833251447901447,0,0,6
327,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6823469227819412,0.8948579431772709,0.34202997756715436,['SRC'],0.8555420132739936,0,0,1
328,Genotoxicity pathway WP4286,0.6892150897211333,0.8447851599469998,0.31443062474696004,"['ITPKC', 'CEBPD']",0.8589002637862148,0,0,2
329,Regulation of Microtubule Cytoskeleton WP2038,0.6892150897211333,0.8447851599469998,0.31443062474696004,"['SRC', 'STAT3']",0.8589002637862148,0,0,2
330,Pathways in clear cell renal cell carcinoma WP4018,0.6916134342688739,0.844520288206295,0.3113983616618329,"['STAT3', 'PDGFB', 'HIF1A']",0.8592772971219342,0,0,3
331,Endoderm differentiation WP2853,0.6977812494238426,0.8442545109211775,0.3038046662718074,"['NOTCH1', 'TRIM5', 'TCF4', 'EZH2']",0.8629007104532017,0,0,4
332,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7019731553643711,0.8450491307634165,0.2990291833609074,['WNT5A'],0.8629007104532017,0,0,1
333,Rett syndrome causing genes WP4312,0.7029483836374862,0.82186104332612,0.2896828518583977,"['CECR2', 'TCF4']",0.8629007104532017,0,0,2
334,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7029483836374862,0.82186104332612,0.2896828518583977,"['MAP3K8', 'PRKCQ']",0.8629007104532017,0,0,2
335,Myometrial relaxation and contraction pathways WP289,0.7138409269115334,0.8346191479753123,0.2813460526115302,"['RYR2', 'CALD1', 'PDE4D', 'PDE4B', 'PRKCQ']",0.8661565060784979,0,0,5
336,Wnt Signaling Pathway WP363,0.716173273825322,0.8001434591589707,0.26711440242136364,"['TCF4', 'ROR2']",0.8661565060784979,0,0,2
337,Fatty Acid Biosynthesis WP357,0.7203887038360189,0.800483351235231,0.2625299989387148,['ACSL1'],0.8661565060784979,0,0,1
338,Oxidative Stress WP408,0.7203887038360189,0.800483351235231,0.2625299989387148,['HMOX1'],0.8661565060784979,0,0,1
339,Physiological and pathological hypertrophy of the heart WP1528,0.7203887038360189,0.800483351235231,0.2625299989387148,['STAT3'],0.8661565060784979,0,0,1
340,Proximal tubule transport WP4917,0.7203887038360189,0.800483351235231,0.2625299989387148,['SLC4A2'],0.8661565060784979,0,0,1
341,Resistin as a regulator of inflammation WP4481,0.7203887038360189,0.800483351235231,0.2625299989387148,['RELA'],0.8661565060784979,0,0,1
342,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.726436189979086,0.8102108262108262,0.25894713289651067,"['RYR2', 'CPT1A', 'YBX1', 'HIF1A']",0.8681925009992598,0,0,4
343,p53 transcriptional gene network WP4963,0.7289001203420615,0.7795395972568034,0.24650489318958574,"['NOTCH1', 'DRAM1']",0.8681925009992598,0,0,2
344,Synaptic Vesicle Pathway WP2267,0.7289001203420615,0.7795395972568034,0.24650489318958574,"['UNC13C', 'SYN3']",0.8681925009992598,0,0,2
345,Calcium Regulation in the Cardiac Cell WP536,0.7306805490885259,0.8164862277213139,0.2561961668091845,"['CHRM3', 'RYR2', 'ATP1B3', 'PRKCQ', 'ADRB2']",0.8681925009992598,0,0,5
346,Alpha 6 Beta 4 signaling pathway WP244,0.7376681322522338,0.7603741496598639,0.23135238225953675,['SRC'],0.8681925009992598,0,0,1
347,DNA Replication WP466,0.7376681322522338,0.7603741496598639,0.23135238225953675,['RPA3'],0.8681925009992598,0,0,1
348,Sphingolipid pathway WP1422,0.7376681322522338,0.7603741496598639,0.23135238225953675,['UGCG'],0.8681925009992598,0,0,1
349,Copper homeostasis WP3286,0.7411399398774169,0.7599659284497444,0.22765981560127593,"['STEAP3', 'SCO2']",0.8681925009992598,0,0,2
350,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7411399398774169,0.7599659284497444,0.22765981560127593,"['PIM1', 'MAP2K6']",0.8681925009992598,0,0,2
351,Glioblastoma signaling pathways WP2261,0.7547930553099552,0.759556313993174,0.21367205228668434,"['SRC', 'PRKCQ', 'MAP2K6']",0.8816671016441072,0,0,3
352,Endometrial cancer WP4155,0.7642051400348489,0.723614829236635,0.19459378925844695,"['CTNNA3', 'FGF2']",0.8901253051542274,0,0,2
353,Pancreatic adenocarcinoma pathway WP4263,0.7822528141856765,0.7231431821875508,0.17758754939003712,"['STAT3', 'DUSP6', 'RELA']",0.8971535674703149,0,0,3
354,GABA receptor Signaling WP4159,0.7833682369618847,0.6609730848861284,0.1613781674434136,['GABRG3'],0.8971535674703149,0,0,1
355,Parkinson's disease pathway WP2371,0.7833682369618847,0.6609730848861284,0.1613781674434136,['LRRK2'],0.8971535674703149,0,0,1
356,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7833682369618847,0.6609730848861284,0.1613781674434136,['CREB5'],0.8971535674703149,0,0,1
357,Tumor suppressor activity of SMARCB1 WP4204,0.7833682369618847,0.6609730848861284,0.1613781674434136,['EZH2'],0.8971535674703149,0,0,1
358,Vitamin D-sensitive calcium signaling in depression WP4698,0.7833682369618847,0.6609730848861284,0.1613781674434136,['ATP2B4'],0.8971535674703149,0,0,1
359,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7943425380041511,0.8350626646081192,0.19226524768456027,"['PTPN1', 'SDF2L1', 'SRC', 'STAT3', 'PXN', 'HSPB1', 'IQGAP1', 'ADRB2', 'PTPN14', 'APOLD1', 'RELA', 'SDCBP', 'TXNIP', 'PFN1', 'CLIC1', 'HSPA1A', 'MAP2K6']",0.9059303629607657,0,0,17
360,IL-1 signaling pathway WP195,0.7954510504045748,0.6751466969524891,0.15450459820136742,"['RELA', 'MAP2K6']",0.9059303629607657,0,0,2
361,Mesodermal commitment pathway WP2857,0.8071257209913942,0.6900403350915296,0.1478589688146101,"['TRIM5', 'TCF4', 'SMAD6']",0.9141165315039161,0,0,3
362,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8093275632583452,0.6079591836734693,0.1286147045504566,['PRKCQ'],0.9141165315039161,0,0,1
363,Neural Crest Cell Migration during Development WP4564,0.8093275632583452,0.6079591836734693,0.1286147045504566,['STAT3'],0.9141165315039161,0,0,1
364,Autophagy WP4923,0.8211181292102543,0.5845107273678702,0.11520022286285887,['ATG14'],0.9194050983184692,0,0,1
365,MAPK Cascade WP422,0.8211181292102543,0.5845107273678702,0.11520022286285887,['MAP2K6'],0.9194050983184692,0,0,1
366,ErbB signaling pathway WP673,0.8223443467454785,0.6695944589439872,0.1309700368490367,"['STAT5A', 'SRC', 'NRG1']",0.9194050983184692,0,0,3
367,Pathways affected in adenoid cystic carcinoma WP3651,0.8229796855679955,0.6327370812038614,0.12327221851841466,"['CEBPA', 'NOTCH1']",0.9194050983184692,0,0,2
368,DNA damage response (only ATM dependent) WP710,0.8295623670657634,0.6598159964386408,0.12329122830481194,"['WNT5B', 'BCL6', 'WNT5A']",0.9196606763509534,0,0,3
369,EGF/EGFR signaling pathway WP437,0.831756775584423,0.7217185330392878,0.13295153685349737,"['STAT5A', 'PLSCR1', 'SRC', 'LIMK2', 'STAT3', 'IQGAP1']",0.9196606763509534,0,0,6
370,Mitochondrial CIV Assembly WP4922,0.8321807583565944,0.5627991937515747,0.10338936588515185,['SCO2'],0.9196606763509534,0,0,1
371,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8321807583565944,0.5627991937515747,0.10338936588515185,['RELA'],0.9196606763509534,0,0,1
372,Disruption of postsynaptic signaling by CNV WP4875,0.8425603209498296,0.5426384839650146,0.09295941049154088,['RYR2'],0.9236623839289575,0,0,1
373,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8425603209498296,0.5426384839650146,0.09295941049154088,['IGF1'],0.9236623839289575,0,0,1
374,Neural Crest Cell Migration in Cancer WP4565,0.8425603209498296,0.5426384839650146,0.09295941049154088,['STAT3'],0.9236623839289575,0,0,1
375,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8522989258256304,0.5238681679568379,0.08372354284373061,['RELA'],0.9269033410835767,0,0,1
376,Netrin-UNC5B signaling pathway WP4747,0.8522989258256304,0.5238681679568379,0.08372354284373061,['SRC'],0.9269033410835767,0,0,1
377,Target Of Rapamycin (TOR) Signaling WP1471,0.8522989258256304,0.5238681679568379,0.08372354284373061,['PRR5'],0.9269033410835767,0,0,1
378,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8614360900893434,0.5063492063492063,0.07552421724043659,['MAP2K6'],0.9343618966577534,0,0,1
379,Glycogen Synthesis and Degradation WP500,0.8700088983681659,0.48996050032916394,0.0682279008926307,['PYGL'],0.9386938113972316,0,0,1
380,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8700088983681659,0.48996050032916394,0.0682279008926307,['SRC'],0.9386938113972316,0,0,1
381,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8725521202241889,0.6314814814814815,0.08609169537905757,"['PTPN1', 'FLOT2', 'MAP3K8', 'MAP2K6']",0.938797211973279,0,0,4
382,Head and Neck Squamous Cell Carcinoma WP4674,0.8746842316433966,0.5517732693201177,0.07387821190460646,"['NOTCH1', 'RELA']",0.938797211973279,0,0,2
383,Histone Modifications WP2369,0.8780521523610014,0.47459608843537415,0.06172088342023871,['EZH2'],0.9399513902559024,0,0,1
384,Alzheimer's disease WP2059,0.88081820837309,0.5418593331710878,0.06876412832990103,"['VMP1', 'APOE']",0.9404569412316846,0,0,2
385,G1 to S cell cycle control WP45,0.8855985110307031,0.4601628530199959,0.05590591156472774,['RPA3'],0.9406616308875344,0,0,1
386,Nucleotide Excision Repair WP4753,0.8855985110307031,0.4601628530199959,0.05590591156472774,['RPA3'],0.9406616308875344,0,0,1
387,16p11.2 proximal deletion syndrome WP4949,0.8922620821276559,0.523057040474652,0.05962608374339831,"['SPN', 'MAP2K6']",0.9428542620421106,0,0,2
388,Pathways Regulating Hippo Signaling WP4540,0.8922620821276559,0.523057040474652,0.05962608374339831,"['PRKCQ', 'CDH18']",0.9428542620421106,0,0,2
389,Splicing factor NOVA regulated synaptic proteins WP4148,0.8993212476084266,0.4337706511175899,0.04602955941791257,['EPB41L3'],0.9478707237003982,0,0,1
390,Hippo-Merlin Signaling Dysregulation WP4541,0.9026786044114542,0.5055082339579784,0.051758335327223216,"['ITGAX', 'CDH18']",0.9489698148940929,0,0,2
391,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9055533756510404,0.42167422524565384,0.04183390239240435,['NOTCH1'],0.949557248125132,0,0,1
392,ATM Signaling Network in Development and Disease  WP3878,0.9114003337602863,0.41023166023166024,0.03805843574050678,['HSPB1'],0.9532503490860137,0,0,1
393,Energy Metabolism WP1541,0.9268606274312958,0.3793367346938776,0.02881141124754224,['PPARD'],0.9669538352336675,0,0,1
394,Ras signaling WP4223,0.9303432045562106,0.5452221452221452,0.03936597871448321,"['GNG10', 'RASA2', 'KSR2', 'RELA']",0.9681236392590007,0,0,4
395,7q11.23 copy number variation syndrome WP4932,0.9389148747236518,0.4391279658296916,0.027678437302930792,"['VPS9D1', 'NRG1']",0.9745698699663221,0,0,2
396,TGF-beta Signaling Pathway WP366,0.9436338836125985,0.4829714617674824,0.028020566512100185,"['SRC', 'LIMK2', 'MAP2K6']",0.9754250340780218,0,0,3
397,Nonalcoholic fatty liver disease WP4396,0.945902105593295,0.5169113887062605,0.028748646010649217,"['VMP1', 'CEBPA', 'XBP1', 'RELA']",0.9754250340780218,0,0,4
398,Small cell lung cancer WP4658,0.9468760086903725,0.3369992441421013,0.018395819865365173,['RELA'],0.9754250340780218,0,0,1
399,AMP-activated protein kinase (AMPK) signaling WP1403,0.9561530794377892,0.31583049886621317,0.014160972240005254,['CPT1A'],0.9808778929138416,0,0,1
400,22q11.2 copy number variation syndrome WP4657,0.9588708832688276,0.3093502707205331,0.012992355618915312,['EMC10'],0.9808778929138416,0,0,1
401,Fragile X Syndrome  WP4549,0.9594588479018418,0.4491433785016727,0.01858818209062495,"['CPT1A', 'SLC16A1', 'SRC']",0.9808778929138416,0,0,3
402,Amino Acid metabolism WP3925,0.9660560180008064,0.29140502354788067,0.010063222792601533,['ARG2'],0.9808778929138416,0,0,1
403,DNA IR-damage and cellular response via ATR WP4016,0.9660560180008064,0.29140502354788067,0.010063222792601533,['BCL6'],0.9808778929138416,0,0,1
404,Integrated breast cancer pathway WP1984,0.9665235822858342,0.4318381277425646,0.014703907290662527,"['ITPKC', 'MAP3K7CL', 'SMAD6']",0.9808778929138416,0,0,3
405,Proteasome Degradation WP183,0.9737251498126297,0.2704689018464529,0.00720155967276936,['PSMB9'],0.9857464479584647,0,0,1
406,Ciliary landscape WP4352,0.9788353384185838,0.4680188037096911,0.010011785353058295,"['CTSA', 'DOCK5', 'CDH23', 'STOM', 'IQGAP1']",0.9884790363340379,0,0,5
407,Ciliopathies WP4803,0.9832366140029176,0.3249253539960799,0.00549301965671801,"['NME9', 'DNAAF4']",0.9904840583321775,0,0,2
408,Cell cycle WP179,0.9885776086804513,0.2191905747806369,0.0025180893553420013,['BUB3'],0.9934235773504535,0,0,1
409,DNA Repair Pathways Full Network WP4946,0.9959083660477286,0.1776110444177671,0.0007282101824176533,['RPA3'],0.9983433498277965,0,0,1
410,mRNA Processing WP411,0.9991784762785859,0.13685837971552256,0.00011247861366383244,['YBX1'],0.9991784762785859,0,0,1
